<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DICYCLOMINE HYDROCHLORIDE</span><br/>(dye-sye'kloe-meen)<br/><span class="topboxtradename">Antispas, </span><span class="topboxtradename">A-spas, </span><span class="topboxtradename">Bentyl, </span><span class="topboxtradename">Bentylol <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Byclomine, </span><span class="topboxtradename">Dibent, </span><span class="topboxtradename">Di-Cyclonex, </span><span class="topboxtradename">Dilomine, </span><span class="topboxtradename">DiSpaz, </span><span class="topboxtradename">Formulex <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Lominex <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Neoquess, </span><span class="topboxtradename">Nospaz, </span><span class="topboxtradename">Or-Tyl, </span><span class="topboxtradename">Protylol <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Spasmoban <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Spasmoject, </span><span class="topboxtradename">Viscerol <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">anticholinergic (parasympatholytic)</span>; <span class="classification">antispasmodic</span><br/><b>Prototype: </b>Atropine<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg, 20 mg capsules; 20 mg tablets; 10 mg/5 mL syrup; 10 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic tertiary amine with antispasmodic properties.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Relieves smooth muscle spasm in GI and biliary tracts, uterus, and ureters by nonspecific direct relaxant action.</p>
<h1><a name="uses">Uses</a></h1>
<p>Adjunctively in treatment of functional bowel disorders/irritable bowel syndrome.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Acute enterocolitis, peptic ulcer, and infant colic.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to anticholinergic drugs; obstructive diseases of GU and GI tracts, paralytic ileus, intestinal atony, biliary
         tract disease; unstable cardiovascular status; severe ulcerative colitis, toxic megacolon; myasthenia gravis; infants 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Glaucoma; prostatic hypertrophy; autonomic neuropathy; ulcerative colitis; hyperthyroidism; coronary heart disease, CHF, arrhythmias,
         hypertension; hepatic or renal disease; hiatal hernia associated with esophageal reflux.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Irritable Bowel Disorders</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2040 mg q.i.d. <span class="rdroute">IM</span> 20 mg q.i.d.<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 10 mg t.i.d. or q.i.d. (max: 40 mg/d)<br/><span class="rdage">Infant:</span> <span class="rdroute">PO</span> 5 mg t.i.d. or q.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give 30 min before meals and at bedtime.</li>
</ul><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give deep IM into a large muscle. Do <small>NOT</small> give IV.
         </li>
<li>Store below 30° C (86° F) unless otherwise directed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">All:</span> Dose related. <span class="typehead">Body as a Whole:</span> Allergic reactions; curare-like effect (cyanosis, apnea, respiratory arrest); decreased sweating; suppression of lactation;
      urticaria. <span class="typehead">CNS:</span> Lightheadedness, drowsiness, headache, insomnia, brief euphoria, fever, restlessness, irritability, coma, seizures. <span class="typehead">CV:</span> Fluctuations in heart rate, palpitation, tachycardia. <span class="typehead">GI:</span> <span class="speceff-common">Dry mouth,</span> nausea, <span class="speceff-common">constipation,</span> paralytic ileus, vomiting, diminished sense of taste, bloated feeling. <span class="typehead">Urogenital:</span> Urinary hesitancy, <span class="speceff-common">urinary retention,</span> impotence. <span class="typehead">Special Senses:</span> Blurred vision. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 12 h. <span class="typehead">Duration:</span> 4 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> 80% excreted in urine, 10% in feces. <span class="typehead">Half-Life:</span> 910 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for adverse effects especially in infants. Treatment of infant colic with dicyclomine includes some risk, especially
            in infants 
         </li><li>Monitor I&amp;O to assess for urinary retention.</li>
<li>If drug produces drowsiness and light-headedness, supervision of ambulation and other safety precautions are warranted.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Exercise caution in hot weather. Dicyclomine may increase risk of heatstroke by decreasing sweating, especially in older adults.</li>
<li>Do not drive or engage in other potentially hazardous activities until reaction to drug is known.</li>
<li>Report changes in urine volume, voiding pattern.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>